Macrogenics Newsroom

Macrogenics Analyst Ratings

BenzingaSep 18 07:21 ET

H.C. Wainwright Maintains Macrogenics(MGNX.US) With Hold Rating, Maintains Target Price $4

Moomoo NewsSep 18 06:31 ET

TD Cowen Maintains Macrogenics(MGNX.US) With Hold Rating

Moomoo NewsSep 16 08:31 ET

Stifel Maintains Macrogenics(MGNX.US) With Hold Rating, Maintains Target Price $6

Moomoo NewsSep 16 08:31 ET

Evercore Maintains Macrogenics(MGNX.US) With Buy Rating

Moomoo NewsSep 16 08:31 ET

MacroGenics (MGNX) Receives a Hold From TD Cowen

TipRanksSep 16 07:49 ET

Macrogenics Analyst Ratings

BenzingaAug 21 08:16 ET

H.C. Wainwright Maintains Macrogenics(MGNX.US) With Hold Rating, Maintains Target Price $4

Moomoo NewsAug 21 06:34 ET

Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Medtronic (MDT)

TipRanksAug 21 06:25 ET

Citi Maintains Macrogenics(MGNX.US) With Buy Rating, Cuts Target Price to $14

Moomoo NewsAug 15 20:32 ET

Macrogenics Analyst Ratings

BenzingaAug 15 10:26 ET

Buy Rating Affirmed for MacroGenics: Potential Growth Amid Oncology Trials and Solid Financials

TipRanksAug 9 06:04 ET

MacroGenics (MGNX) Receives a Buy From Barclays

TipRanksAug 8 08:16 ET

Buy Rating Affirmed for MacroGenics Ahead of ESMO Meeting Amidst Positive Financials and Speculative Growth Scenarios

TipRanksAug 8 00:50 ET

Macrogenics Analyst Ratings

BenzingaAug 7 11:13 ET

BMO Capital Maintains Market Perform on Macrogenics, Lowers Price Target to $5

BenzingaAug 7 11:13 ET

Maintaining Hold on MacroGenics: Discontinued Vobra Duo and Low Conviction in Competitive Market

TipRanksAug 7 07:49 ET

TD Cowen Maintains Macrogenics(MGNX.US) With Hold Rating

Moomoo NewsAug 6 20:31 ET

Hold Rating on MacroGenics Amid Trial Uncertainties and Safety Concerns

TipRanksAug 6 19:50 ET

Macrogenics Analyst Ratings

BenzingaAug 1 14:07 ET